Lei Lv

5.7k total citations · 1 hit paper
127 papers, 3.9k citations indexed

About

Lei Lv is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Lei Lv has authored 127 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 21 papers in Immunology and 20 papers in Oncology. Recurrent topics in Lei Lv's work include Epigenetics and DNA Methylation (20 papers), RNA modifications and cancer (13 papers) and Cancer, Hypoxia, and Metabolism (11 papers). Lei Lv is often cited by papers focused on Epigenetics and DNA Methylation (20 papers), RNA modifications and cancer (13 papers) and Cancer, Hypoxia, and Metabolism (11 papers). Lei Lv collaborates with scholars based in China, United States and India. Lei Lv's co-authors include Yue Xiong, Yanping Xu, Qun‐Ying Lei, Kun‐Liang Guan, Di Zhao, Xin Zhou, Ruiting Lin, Qian Bu, Yinglan Zhao and Ying Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Lei Lv

121 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1

2022 160 citations Ruonan Zhang, Yajing Yang et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Lei Lv

Since Specialization

Citations

This map shows the geographic impact of Lei Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Lv more than expected).

Fields of papers citing papers by Lei Lv

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Lv. The network helps show where Lei Lv may publish in the future.

Co-authorship network of co-authors of Lei Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Lv. A scholar is included among the top collaborators of Lei Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Lv. Lei Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HNF4α-TET2-FBP1 axis contributes to gluconeogenesis and type 2 diabetes 2025 ·eLife ·(unknown), Xinchao Zhang, (unknown), (unknown), (unknown), Xinyu Zhao, Kai Wang, Bingbing Zha, Haijie Ma, Ming Xu, Lei Lv, Yanping Xu	0
2	TET2 orchestrates YAP signaling to potentiate targetable vulnerability in hepatocellular carcinoma 2025 ·Cell Death and Disease ·(unknown), Mingen Lin, Fei Teng, (unknown), (unknown), (unknown), Yan Ma, Yue Dai, Yi Gao, (unknown), Tongguan Tian, (unknown), Xinxing Li, Lei Lv, Yanping Xu	0
3	p53 inhibits OTUD5 transcription to promote GPX4 degradation and induce ferroptosis in gastric cancer 2025 ·Clinical and Translational Medicine ·(unknown), Tongguan Tian, Xinxing Li, Kai Xu, Yao Lu, Xia Li, Xinyu Zhao, (unknown), Zhenxiang Wang, (unknown), Yixin Xu, (unknown), (unknown), Yu Du, Lei Lv, Yanping Xu	6
4	D-mannose alleviates chronic periodontitis in rats by regulating the functions of neutrophils 2024 ·BMC Oral Health ·Xue Li, Xueting Chen, Qingyu Zhu, (unknown), (unknown), Lei Lv, Shengcai Qi	4
5	Coupled influence of geosynthetic reinforcement and column configuration on failure dynamics in deep mixed columns under embankment loading 2024 ·Acta Geotechnica ·Gang Zheng, Lei Lv, Xiaoxuan Yu, Haizuo Zhou	5
6	HNF4α-TET2-FBP1 axis contributes to gluconeogenesis and type 2 diabetes 2024 ·eLife ·(unknown), Xinchao Zhang, (unknown), (unknown), (unknown), Xinyu Zhao, Kai Wang, Bingbing Zha, Haijie Ma, Ming Xu, Lei Lv, Yanping Xu	1
7	The value of home-uroflowmetry in evaluation of voiding function in children with overactive bladder 2024 ·Journal of Pediatric Urology ·Shuai Yang, Zhaokai Zhou, Jing Yang, (unknown), Yibo Wen, Xingchen Liu, Yanping Zhang, Lei Lv, Jinhua Hu, Israel Franco, Konstantinos Kamperis, Søren Rittig, Qingwei Wang, Jianguo Wen	1
8	D-mannose induces TFE3-dependent lysosomal degradation of EGFR and inhibits the progression of NSCLC 2023 ·Oncogene ·(unknown), (unknown), Jing He, (unknown), Xuhui Yang, Wenjing Dong, (unknown), (unknown), Yanping Xu, Lei Lv	4
9	TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potential 2023 ·Cell Discovery ·Jing He, Mingen Lin, Xinchao Zhang, Ruonan Zhang, Tongguan Tian, (unknown), (unknown), Yajing Yang, (unknown), Yue Dai, Yue Xu, (unknown), Ming Xu, Qun‐Ying Lei, Yanping Xu, Lei Lv	9
10	Balancing dynamic evolution of active sites for urea oxidation in practical scenarios 2023 ·Energy & Environmental Science ·Jichao Zhang, Jiexin Zhu, Liqun Kang, Qing Zhang, Longxiang Liu, (unknown), Kaiqi Li, Jianrui Feng, Lixue Xia, Lei Lv, Wei Zong, Paul R. Shearing, Dan J. L. Brett, Ivan P. Parkin, Xuedan Song, Liqiang Mai, Guanjie He	60
11	FBXO38 mediates FGL1 ubiquitination and degradation to enhance cancer immunity and suppress inflammation 2023 ·Cell Reports ·Tongguan Tian, (unknown), Wanwan Yi, (unknown), Yixin Xu, Zhenxiang Wang, Junjing Zhang, Mingen Lin, Ruonan Zhang, Zhongwei Lv, Xinxing Li, Lei Lv, Yanping Xu	13
12	CDK5 destabilizes PD-L1 via chaperon-mediated autophagy to control cancer immune surveillance in hepatocellular carcinoma 2023 ·Journal for ImmunoTherapy of Cancer ·Ruonan Zhang, Jie Wang, Yu Du, Ze Yu, Yihan Wang, Yixiao Jiang, Yixin Wu, Ting Le, Ziqi Li, (unknown), Lei Lv, Haijie Ma	18
13	D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1 breakdown → 2022 ·Proceedings of the National Academy of Sciences ·Ruonan Zhang, Yajing Yang, Wenjing Dong, Mingen Lin, Jing He, Xinchao Zhang, Tongguan Tian, Yunlong Yang, Kun Chen, Qun‐Ying Lei, Song Zhang, Yanping Xu, Lei Lv	160
14	TET2 Suppresses VHL Deficiency-Driven Clear Cell Renal Cell Carcinoma by Inhibiting HIF Signaling 2022 ·Cancer Research ·(unknown), Shuyan Li, Jing He, (unknown), Ruonan Zhang, Wenjing Dong, Mingen Lin, Yajing Yang, Tongguan Tian, (unknown), Yixin Xu, Qun‐Ying Lei, Jing Zhang, Qing Zhang, Yanping Xu, Lei Lv	34
15	Erythropoietin prevented the decreased expression of aquaporin1–3 in ureteral obstructive kidneys in juvenile rats 2022 ·Pediatric Research ·Jinjin Feng, Jianguo Wen, Yanping Zhang, Biao Dong, (unknown), Shuanbao Yu, (unknown), (unknown), Lei Lv, Xuepei Zhang	1
16	USP15 suppresses tumor immunity via deubiquitylation and inactivation of TET2 2020 ·Science Advances ·(unknown), Matthew D. Smith, Lei Lv, Tadashi Nakagawa, Zhijun Li, Shao‐Cong Sun, Nicholas G. Brown, Yue Xiong, Yanping Xu	37
17	Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy 2019 ·Journal of Clinical Investigation ·Yanping Xu, Lei Lv, Ying Liu, Matthew D. Smith, Wencai Li, Xianming Tan, Meng Cheng, Zhijun Li, (unknown), Jeffrey Aubé, Yue Xiong	181
18	Downregulation of Pin1 in human atherosclerosis and its association with vascular smooth muscle cell senescence 2017 ·Journal of Vascular Surgery ·Lei Lv, Meng Ye, (unknown), Kai Yuan, Jiaquan Chen, Wei Liang, (unknown), Lan Zhang	21
19	Oxidative Stress Activates SIRT2 to Deacetylate and Stimulate Phosphoglycerate Mutase 2014 ·Cancer Research ·Yanping Xu, Fulong Li, Lei Lv, Tingting Li, Xin Zhou, Chu‐Xia Deng, Kun‐Liang Guan, Qun‐Ying Lei, Yue Xiong	128
20	Cellular Retinaldehyde-Binding Protein-Like (CRALBPL), a Novel Human Sec14p-Like Gene That Is Upregulated in Human Hepatocellular Carcinomas, May Be Used as a Marker for Human Hepatocellular Carcinomas 2008 ·DNA and Cell Biology ·Shuo Zhao, (unknown), Hui Qian, Lei Lv, Chaoneng Ji, Chunjing Chen, Xin Zhao, Dan Zheng, Shaohua Gu, Yi Xie, Yumin Mao	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact